The Drug Topics 2009 rate card
FDA Approves Omalizumab-Igec as First Interchangeable Biosimilar to Xolair
Omalizumab-igec is approved to treat moderate to severe persistent asthma in patients 6 years and older whose symptoms are not well controlled with inhaled corticosteroids.
Dispensing Leadership: Defining Your Philosophy
Join Shawn Bjorndal, PharmD, RPh, and Jesse McCullough, PharmD, for the first episode of Dispensing Leadership, a new podcast from Drug Topics® and RPhAlly.
Premature, Early Menopause Linked With Increased Type 2 Diabetes Risk
After adjusting for confounding factors, women who experienced premature menopause had an increased risk of T2D.
How Barbershops Are Becoming Community Health Care Destinations
The Cut Hypertension Program operates in barbershops across the Bay Area in California. The program’s lead pharmacist joined us to discuss main themes and goals of the new initiative.
New Interventions Needed to Improve Rate of Pharmacy No-Shows
Clinical pharmacists were asked to provide interventions to improve their patients’ rate of not showing up to a pharmacy appointment.
Nonopioid Therapy For Acute Pain Shows Positive Results in Phase 3 Trial
Cebranopadol met its primary endpoint of reduction in pain intensity as measured by the Pain Numeric Rating Scale (NRS) area under the curve from 2 through 48 hours.
